Clinical trial
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug…
NCT00067951 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00067951 |
|---|---|
| Title | A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics |
| Official title | An Open-label Trial to Evaluate the Safety and Efficacy of Fixed Dose Rosiglitazone/Metformin Combination Therapy in Poorly-controlled Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | rosiglitazone/metformin |
| Enrollment | 190 |
| Start date | Oct 17, 2003 |
| Primary completion | Nov 1, 2004 |
| Completion | Nov 30, 2004 |
| First posted | Sep 5, 2003 |
| Last update posted | Mar 21, 2018 |
| Countries | Australia, Canada, New Zealand, South Korea, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: